NumFin

IDEXX Laboratories, Inc.

Sümbol: IDXX

NASDAQ

500.82

USD

Turuhind täna

  • 48.0241

    P/E suhe

  • 3.4962

    PEG suhe

  • 41.36B

    MRK Cap

  • 0.00%

    DIV tootlus

IDEXX Laboratories, Inc. (IDXX) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete IDEXX Laboratories, Inc. (IDXX) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes IDEXX Laboratories, Inc. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991

balance-sheet.row.cash-and-short-term-investments

0453.9112.5144.5
383.9
90.3
123.8
471.9
391.9
342.6
322.5
279.1
224
183.9
156.9
106.7
78.9
60.4
96.7
132.7
137.3
220.7
147.2
79.6
75.2
58.6
109.1
107
127.7
149.3
25.2
18.9
17.2
9.3

balance-sheet.row.short-term-investments

0000
0
0
0
284.3
236.9
213.6
0
0
0
0
0
0
0
0
35
65.6
90.1
34
33.4
12.9
29.2
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

0457.4400.6368.3
331.4
269.3
248.9
234.6
204.5
188.3
152.4
158
138.3
141.3
120.1
115.1
111.5
108.4
81.4
71.7
65.6
54
45.7
50.8
57.3
58.4
47.9
47.3
66.6
47.3
25.8
21.4
11.9
10.5

balance-sheet.row.inventory

0380.3367.8269
209.9
195
173.3
164.3
158
188.8
160.3
133.4
140.9
133.1
127.9
110.4
115.9
98.8
96
69.4
76.4
75.3
75.1
86.2
65.9
47.5
55.4
60.2
48.4
28.2
20.8
14.6
12.8
5.1

balance-sheet.row.other-current-assets

0203.6220.5173.8
137.5
125
108.2
101.1
91.2
101.9
124.1
82.2
66.3
66
55.7
44.1
49.6
14.5
11.3
11.7
8.8
6.8
6.3
4.8
17.4
67.9
50.9
59.7
59
37.2
26.7
21.9
15.5
1.5

balance-sheet.row.total-current-assets

01495.31101.5955.7
1062.7
679.6
654.2
972
845.6
821.6
759.4
652.7
569.5
524.2
460.6
376.3
355.9
305.7
302.3
299.2
301.6
370.6
289.1
235.6
215.8
232.4
263.3
274.2
301.7
262
98.5
76.8
57.4
26.4

balance-sheet.row.property-plant-equipment-net

0702.2649.5587.7
555.2
533.8
437.3
379.1
357.4
333
303.6
281.2
245.2
216.8
201.7
199.9
189.6
141.9
99.6
65.7
62.6
45.2
49.5
49.2
45.7
39.6
41.5
41
36.4
25.5
13.4
12
11.7
11

balance-sheet.row.goodwill

0366361.8359.3
243.3
239.7
214.5
199.9
178.2
178.9
184.4
180.5
175
172.6
149.1
148.7
138.8
236.4
104.8
88.1
0
55
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

084.597.799
52.5
58.5
41.8
43.8
46.2
55.9
65.1
58.8
62.8
69.2
55.8
63.9
68.3
0
43.4
118.7
124.5
61.8
56.2
0
0
0
0
0
0
0
8.2
8.9
10.3
0

balance-sheet.row.goodwill-and-intangible-assets

0450.5459.5458.4
295.9
298.2
256.3
243.7
224.4
234.8
249.6
239.4
237.8
241.8
204.9
212.6
207.1
236.4
148.2
118.7
124.5
61.8
56.2
0
0
0
0
0
0
0
8.2
8.9
10.3
0

balance-sheet.row.long-term-investments

056.255.513.3
12.1
13.7
10.9
9.9
11
12.2
10.8
13.1
10.3
-267.5
-205.5
-213.6
-208.3
0
0
-13.8
19.7
35.1
15.6
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0107.455.224.8
31.5
8.1
8.5
7.7
39.3
39.8
37.7
33.2
27.7
25.6
0.6
1
1.2
6.6
3.3
13.8
13.5
13.8
14.9
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0448.5425.6397.4
337.2
299
170.2
101
53
33.5
23.2
10.9
13
289.8
234.8
232.2
219.9
11.6
6.2
7
-7.6
-4.6
-8.5
88.3
74.3
88.2
85.7
61.8
35.8
25
1.6
0.3
0.3
0.7

balance-sheet.row.total-non-current-assets

01764.71645.31481.5
1231.8
1152.8
883.2
741.4
685.1
653.4
624.8
577.8
534.1
506.6
436.6
432.2
409.5
396.5
257.3
191.4
212.6
151.3
127.5
137.5
120
127.8
127.2
102.8
72.2
50.5
23.2
21.2
22.3
11.7

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

03259.92746.82437.2
2294.6
1832.5
1537.3
1713.4
1530.7
1475
1384.2
1230.5
1103.6
1030.8
897.1
808.5
765.4
702.2
559.6
490.7
514.2
521.9
416.7
373.1
335.8
360.2
390.5
377
373.9
312.5
121.7
98
79.7
38.1

balance-sheet.row.account-payables

0110.6110.2116.1
74.6
72.2
69.5
67
60.1
52.6
44.7
29.9
35.3
36.6
22.7
19.1
28
32.5
24.4
19.8
14.7
19.2
9.4
10.9
13.7
19.6
26.8
12.5
18.7
10.8
9.2
7.2
4.3
3.1

balance-sheet.row.short-term-debt

0325654148.5
50
288.8
398.9
655
611
573
549
278
213.1
243.9
129.9
119.6
151.4
73
0.7
0.6
1.3
0.5
1
8.4
8.5
3.3
5.2
4.1
3
1.7
0
0
0
0

balance-sheet.row.tax-payables

086.648.542.6
42.7
31.1
26.6
29.4
24
19
28.4
16.5
14.9
0
12.3
10
13.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0622.9694.4775.2
858.5
698.9
601.3
606.1
593.1
597.1
350
150.4
1.4
2.5
3.4
4.3
5.1
5.7
6.4
-7.8
0.4
0.8
0
0
0
0.3
4.2
0
0
0
0
0
0
0

Deferred Revenue Non Current

028.530.941.2
46.2
48.7
60.7
35.5
33
27.1
21.7
18.4
12.7
10.8
4.6
3.8
3.8
6.2
6.8
7.8
6.3
5.8
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0478.7433.7458.9
415.6
322.9
260.7
253.4
236.1
205.5
195.4
148.9
137.7
141.4
118.6
105
104.6
107.2
90.7
78.2
73.8
72.8
51.7
38.9
51.9
52.6
46.5
57.7
29.4
20.9
12.8
7.1
5.1
3.5

balance-sheet.row.total-non-current-liabilities

0823.8902.2983.6
1079
929.3
776.1
762.7
704.3
702.2
445.7
233.9
61
54.3
37.8
37.6
32
40.5
25
14.8
16.6
7.8
6.2
0
0
0.4
4.2
1.4
0.1
0
-0.1
0.1
-0.1
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-6.2
0
0
0
0
-1.4
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0119.5121.7107.3
94.8
82.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

01775.421381747.2
1661.8
1654.7
1546.6
1767.3
1638.9
1559
1266.6
712.3
467.3
491.2
322.9
293.9
327.2
263.9
149.7
121.4
116.6
108.6
75.7
71.4
74
75.9
82.7
74.3
51.2
33.4
21.9
14.4
9.3
6.6

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

010.810.710.7
10.6
10.6
10.5
10.4
10.3
10.3
10.2
10.1
10
9.9
9.8
9.6
9.5
9.4
4.7
4.6
4.5
4.4
4.2
4.1
4
4
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

04444.63599.52920.4
2175.6
1595.6
1167.9
803.5
540.4
318.4
1675.3
1493.4
1305.6
1127.3
965.5
824.3
702
585.9
490.6
396.9
318.7
240.3
183.3
137.9
100.3
63.6
31
46.3
67.4
45.2
23.7
10.4
0.4
-4.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-71.2-77.8-53.5
-53.6
-46.2
-41.8
-36.5
-43.1
-42.3
-8.1
13.6
16
15.4
13.5
10.3
5.7
24.9
12.4
2.2
12
4.7
-2.5
-6.7
-5
-3.5
-41
-30.4
-22.9
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0-2899.6-2923.7-2187.7
-1500.5
-1382.6
-1146.2
-831.6
-616
-370.5
-1559.9
-998.9
-695.3
-613.1
-414.6
-329.7
-279.1
-181.9
-97.8
-34.7
62.5
163.8
156
166.4
162.4
220.2
317.8
286.8
278.2
233.9
76.1
73.2
70
36

balance-sheet.row.total-stockholders-equity

01484.5608.7690
632.1
177.5
-9.5
-54.1
-108.4
-84.1
117.5
518.2
636.2
539.6
574.2
514.6
438.2
438.3
409.9
369
397.7
413.3
341
301.7
261.7
284.3
307.8
302.7
322.7
279.1
99.8
83.6
70.4
31.5

balance-sheet.row.total-liabilities-and-stockholders-equity

03259.92746.82437.2
2294.6
1832.5
1537.3
1713.4
1530.7
1475
1384.2
1230.5
1103.6
1030.8
897.1
808.5
765.4
702.2
559.6
490.7
514.2
521.9
416.7
373.1
335.8
360.2
390.5
377
373.9
312.5
121.7
98
79.7
38.1

balance-sheet.row.minority-interest

0000
0.7
0.4
0.3
0.3
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

01484.5608.7690
632.8
177.8
-9.2
-53.8
-108.2
-84
117.6
518.2
636.3
539.6
574.3
514.6
438.2
438.3
409.9
369.3
397.7
413.3
341
301.7
261.7
284.3
307.8
302.7
322.7
279.1
99.8
83.6
70.4
31.5

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

056.255.513.3
12.1
13.7
10.9
294.2
247.9
225.8
10.8
13.1
10.3
-267.5
-205.5
-213.6
-208.3
0
35
65.6
109.8
69.1
49
12.9
29.2
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

0947.91348.4923.7
908.5
987.7
1000.3
1261.1
1204.1
1170.1
899
428.4
214.5
246.4
133.3
123.9
156.5
78.7
7.1
0.6
1.7
1.3
1
8.4
8.5
3.6
9.4
4.1
3
1.7
0
0
0
0

balance-sheet.row.net-debt

0493.91235.8779.2
524.6
897.3
876.5
1073.4
1049.2
1041.1
576.5
149.3
-9.5
62.5
-23.6
17.2
77.6
18.3
-54.5
-66.6
-45.5
-185.4
-112.8
-58.3
-37.5
-55
-99.7
-102.9
-124.7
-147.6
-25.2
-18.9
-17.2
-9.3

Rahavoogude aruanne

IDEXX Laboratories, Inc. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991

cash-flows.row.net-income

0845679.1744.8
582.1
427.8
377
263.3
222.1
192.1
182
187.8
178.3
161.8
141.3
122.2
116.2
94
93.7
78.3
78.3
57.1
45.4
37.6
36.6
32.6
-15.2
-21.1
32.6
21.5
13.3
9.7
4.9
3.2

cash-flows.row.depreciation-and-amortization

0114.9111.9104.6
96
88
83.2
83.1
78.2
69
58.9
54.6
52.4
48.2
46
49.8
48.8
41.1
29.8
24.4
18.4
18.9
20.1
22.2
19.5
17.2
15.9
14.4
10.4
5.7
4.5
3.8
3.5
1

cash-flows.row.deferred-income-tax

0-48.3-35.1-3.4
-38.1
6.2
1.2
-7.9
20.9
5.1
0.8
2.1
-2
6
-0.9
3.3
5.6
-9.1
-6.1
-4.5
4.6
-1.2
3.8
-0.4
3.4
2
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

059.749.837.8
31
39.3
25.2
23.5
19.9
19.9
18.1
16.5
16
15.5
13.3
11.6
10.5
8.8
10.8
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-72.4-273.5-137.5
-31.8
-105
-91.6
8.4
3
-69.8
-9.7
-3.1
2.3
6.5
-3.1
-11.6
-33.2
-1
-10.2
10.7
-13.6
21.8
33.1
-13.1
-31.3
0.8
8.1
5.4
-35
-20.5
-3.2
-6.1
-8.6
-0.3

cash-flows.row.account-receivables

0-53.9-41.4-33.1
-60.7
-22.5
-18.4
-24.9
-22.6
-50.1
-3.6
-15.9
3.5
-24.8
-6.9
-1.2
-10.3
-25.5
-6.6
-5.2
-5.2
-5.6
7.8
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-28.7-121.7-52.9
-18.9
-37.3
-25.6
-19.1
7.6
-35
-38.3
-1.3
-13.8
-6.3
-19.5
6.2
-18.5
-5.2
-25.7
7.4
0.8
0.1
11.4
-20.3
-28.5
5.2
4.9
-11.2
-19.2
-7.4
-6.2
-1.6
-4.3
-0.6

cash-flows.row.account-payables

0-0.63.511.2
1
2
-0.2
1.4
2.1
-2.5
6.7
-4.4
-1.3
13.9
3.5
-9.2
-4.3
5.9
4.4
-5.8
-5.8
9.6
-1.6
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

010.7-113.9-62.7
46.9
-47.1
-47.5
51
15.8
17.8
25.5
18.6
13.8
23.7
19.8
-7.5
-0.1
23.9
17.7
14.3
-3.4
17.8
15.4
7.2
-2.7
-4.4
3.2
16.6
-15.8
-13.1
3
-4.5
-4.3
0.3

cash-flows.row.other-non-cash-items

07.610.89.3
8.8
2.9
5.1
2.9
-9.5
0.1
-14.2
-11.9
-16.7
-17.3
-17.7
-1.6
-4.6
1.3
-8.1
7.5
7.5
20.4
0.9
0
0
0
37.3
14.8
0
0.1
0.2
0
0.1
-0.1

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-133.6-148.8-119.5
-107.6
-155.2
-122.9
-76.7
-64.8
-82.9
-60.7
-78.6
-69
-100.2
-39.3
-57.8
-90
-66.2
-71.4
-24.2
-31.7
-16.9
-15.1
-17.4
-15.5
-12.4
-48.1
-35.5
-11.8
-15.9
-4.4
-2.1
-2.3
-9.4

cash-flows.row.acquisitions-net

00-46.5-173.4
-1.8
-50.3
-22.5
-14.6
-2
-10.3
-19.7
-7.4
3
3
0
3.4
-8.6
-89.9
39
-10.2
-53.9
-2.3
-1.4
0
-11.9
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

00-250
0
0
-0.1
-334.2
-227.9
-272
-5.4
0
0
0
-4
0
0
1.1
-79.8
-63.6
-37.1
-58.2
-32.6
-4.6
10.4
-25.8
0
0
-5.1
-22.8
-4.8
-6.5
-8.5
-5.2

cash-flows.row.sales-maturities-of-investments

08.471.50
0
0
284.1
286.8
203.9
56.8
5.4
0
0
0
0
0
0
35
110.5
107.9
86
37.9
18.7
0
43.2
0
0
6.5
0
0
0
0
0
0

cash-flows.row.other-investing-activites

00-46.50
0
0
0
0
0
0
0
0
0
0.2
0.1
2.1
7
-1.1
-39
2.8
0
-2.7
-2.4
-4.2
-1.9
-0.8
-0.3
-3.7
-21.6
-3.6
-2.2
-0.2
-10.1
-1.5

cash-flows.row.net-cash-used-for-investing-activites

0-125.3-195.3-293
-109.4
-205.5
138.6
-138.7
-90.8
-308.4
-80.4
-86.1
-66
-97
-43.2
-52.4
-91.6
-121.1
-40.7
12.6
-36.8
-42.2
-32.8
-26.2
24.2
-39
-48.4
-32.7
-38.5
-42.3
-11.4
-8.8
-20.9
-16.1

cash-flows.row.debt-repayment

0-404-75-50
-289.6
-110.3
-256
0
0
0
-1.4
-1.1
-31.9
-0.9
-0.8
-33.8
-0.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

04735.746.6
51.3
36.1
0
0
0
0
0
0
0
0
0
0
0
20.9
20.9
18.8
19.4
31.2
11.9
14
10.2
6.6
5.8
3
11.9
158.1
2.4
2.3
29.4
14.3

cash-flows.row.common-stock-repurchased

0-71.9-830.3-762.3
-203.4
-309.7
-378.7
-290.6
-304.1
-402
-618.2
-367.8
-132.3
-255.5
-143.1
-83.1
-132.3
-118.4
-105.7
-123.8
-129.2
-35.8
-29.8
-13
-70.3
-64.2
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

000-46.6
-51.3
-36.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0-13.1498.6114.9
244.6
133.6
36.9
82.6
86.3
306.4
516.1
266.4
38.8
158.7
57.1
21.6
102.1
79.3
8.5
-2.1
-0.4
-0.5
-7.5
-0.1
-3.3
-6.4
-2.6
-1.5
-1.9
1.6
0
0.1
0
-0.1

cash-flows.row.net-cash-used-provided-by-financing-activities

0-442-370.9-697.4
-248.4
-286.4
-597.8
-208
-217.8
-95.6
-103.4
-102.5
-125.3
-97.7
-86.8
-95.3
-30.8
-18.2
-76.3
-107
-110.2
-5.2
-25.3
0.9
-63.4
-64
3.2
1.5
10
159.7
2.4
2.4
29.4
14.2

cash-flows.row.effect-of-forex-changes-on-cash

02.1-8.6-4.6
3.3
-0.7
-4.8
6.2
-0.1
-5.9
-8.5
-2.4
1.2
0.9
1.3
1.8
-2.5
2.9
1.6
-2.2
1.8
3.2
2
-0.4
-1.7
-0.1
1.2
-3.1
-1
-0.2
0.4
-0.1
-0.5
-0.2

cash-flows.row.net-change-in-cash

0341.4-31.9-239.5
293.6
-33.5
-63.9
32.8
25.9
-193.5
43.5
55.1
40.1
27
50.2
27.9
18.5
-1.3
-5.5
20
-49.8
72.9
47.1
20.7
-12.6
-50.5
2.1
-20.8
-21.5
124
6.2
0.9
7.9
1.7

cash-flows.row.cash-at-end-of-period

0453.9112.5144.5
383.9
90.3
123.8
187.7
154.9
129
322.5
279.1
224
183.9
156.9
106.7
78.9
60.4
61.7
67.2
47.2
186.7
113.8
66.7
46
58.6
109.1
106.9
127.8
149.2
25.1
18.9
17.2
9.3

cash-flows.row.cash-at-beginning-of-period

0112.5144.5383.9
90.3
123.8
187.7
154.9
129
322.5
279.1
224
183.9
156.9
106.7
78.9
60.4
61.7
67.2
47.2
96.9
113.8
66.7
46
58.6
109.1
107
127.7
149.3
25.2
18.9
18
9.3
7.6

cash-flows.row.operating-cash-flow

0906.5543755.5
648.1
459.2
400.1
373.3
334.6
216.4
235.8
246
230.3
220.7
178.8
173.7
143.3
135.1
109.8
116.6
95.4
117.2
103.3
46.4
28.2
52.6
46.1
13.5
8
6.8
14.8
7.4
-0.1
3.8

cash-flows.row.capital-expenditure

0-133.6-148.8-119.5
-107.6
-155.2
-122.9
-76.7
-64.8
-82.9
-60.7
-78.6
-69
-100.2
-39.3
-57.8
-90
-66.2
-71.4
-24.2
-31.7
-16.9
-15.1
-17.4
-15.5
-12.4
-48.1
-35.5
-11.8
-15.9
-4.4
-2.1
-2.3
-9.4

cash-flows.row.free-cash-flow

0772.9394.1636
540.4
303.9
277.1
296.6
269.8
133.4
175.1
167.4
161.2
120.5
139.5
115.9
53.4
68.9
38.5
92.4
63.7
100.3
88.2
29
12.7
40.2
-2
-22
-3.8
-9.1
10.4
5.3
-2.4
-5.6

Kasumiaruande rida

IDEXX Laboratories, Inc. tulud muutusid võrreldes eelmise perioodiga NaN%. IDXX brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991

income-statement-row.row.total-revenue

036613367.33215.4
2706.7
2406.9
2213.2
1969.1
1775.4
1601.9
1485.8
1377.1
1293.3
1218.7
1103.4
1031.6
1024
922.6
739.1
638.1
549.2
476
412.7
386.1
367.4
356.2
319.9
263
267.7
188.6
126.4
93.1
57.7
30.5

income-statement-row.row.cost-of-revenue

0147113631325.9
1135.6
1041.4
971.7
871.7
800
711.6
669.7
620.9
594.2
572.2
524.8
505.4
494.3
459
359.6
315.2
270.2
245.7
219.9
202.8
170.8
164.9
142.2
119.8
102.9
75.2
48.7
34.2
21.7
11.8

income-statement-row.row.gross-profit

021902004.31889.4
1571
1365.5
1241.5
1097.4
975.4
890.3
816.1
756.1
699.1
646.5
578.6
526.3
529.8
463.5
379.5
322.9
279
230.3
192.7
183.3
196.7
191.3
177.7
143.2
164.8
113.4
77.7
58.9
36
18.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

002.21.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.operating-expenses

01092.81105.6957.4
876.5
812.7
750.2
684.4
625.2
582.1
555.9
489.4
436.6
410.3
374.7
350.3
357.3
327.3
251.6
207.6
171
149.9
126.9
126.8
143.4
144.5
148.6
147.6
117.8
80.5
54.9
45
30.9
16.1

income-statement-row.row.cost-and-expenses

02563.82468.62283.3
2012.1
1854.1
1721.9
1556
1425.2
1293.8
1225.6
1110.3
1030.8
982.5
899.5
855.7
851.6
786.4
611.2
522.8
441.1
395.6
346.9
329.5
314.2
309.4
290.8
267.4
220.7
155.7
103.6
79.2
52.6
27.9

income-statement-row.row.interest-income

05.61.10.4
0.6
0.4
1.2
5.3
3.7
2.5
1.7
1.9
1.9
1.7
0.7
0.5
2.3
2.8
3.3
3.1
3.1
2.9
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

0-3638.829.4
32.5
30.6
33.6
32
28.4
26.8
13.7
3.5
1.9
1.8
1.8
1.4
4.6
-4.2
-0.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-36-38.8-29.4
-32.5
-30.6
-33.6
-32
-28.4
-8.2
-13.7
-3.5
-1.9
-1.8
-1.8
-1.4
-2.3
-1.3
0.2
0.5
0.4
0.1
3
2.2
5
5.8
-30.3
-27.8
8.3
4.1
0.1
1.1
1
0.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

002.21.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.total-operating-expenses

0-36-38.8-29.4
-32.5
-30.6
-33.6
-32
-28.4
-8.2
-13.7
-3.5
-1.9
-1.8
-1.8
-1.4
-2.3
-1.3
0.2
0.5
0.4
0.1
3
2.2
5
5.8
-30.3
-27.8
8.3
4.1
0.1
1.1
1
0.8

income-statement-row.row.interest-expense

0-3638.829.4
32.5
30.6
33.6
32
28.4
26.8
13.7
3.5
1.9
1.8
1.8
1.4
4.6
-4.2
-0.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

0114.9111.9104.6
96
88
83.2
83.1
78.2
69
58.9
54.6
52.4
48.2
46
49.8
48.8
41.1
29.8
24.4
18.4
18.9
20.1
22.2
19.5
17.2
15.9
14.4
10.4
5.7
4.5
3.8
3.5
1

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

01097.1898.8932
694.5
552.8
491.3
413
350.2
299.9
260.3
266.8
262.6
236.2
203.9
176
172.5
136.2
127.9
115.3
108
80.4
65.8
56.6
53.3
46.8
29.1
-4.4
47
32.9
22.8
13.9
5.1
2.6

income-statement-row.row.income-before-tax

01061.2860902.7
662
522.2
457.7
381.1
321.8
273.1
246.6
263.3
260.6
234.4
202.1
174.5
170.2
134.8
130.8
118.5
111.1
83.3
68.8
58.8
58.2
52.6
-1.2
-32.2
55.3
37
22.8
15.1
6.1
3.5

income-statement-row.row.income-tax-expense

0216.1180.9157.8
79.9
94.4
80.7
117.8
99.8
81
64.6
75.5
82.3
72.7
60.8
52.3
54
40.8
37.2
40.7
33.2
26.3
23.4
21.2
21.6
20
14
-11.1
22.7
15.5
9.5
5.4
1.2
0.3

income-statement-row.row.net-income

0845679.1744.8
581.8
427.7
377
263.1
222
192.1
181.9
187.8
178.3
161.8
141.3
122.2
116.2
94
93.7
78.3
78.3
57.1
45.4
37.6
36.6
32.6
-15.2
-21.1
32.6
21.5
13.3
9.7
4.9
3.2
Sarnased aktsiad
Sind võib huvitada ka:
8225.HK
China Health Group Inc..
0.119 HKD
HKSE
RVTY
Revvity, Inc..
104.34 USD
NYSE
LAB
Standard BioTools Inc..
2.41 USD
NASDAQ
8037.HK
China Biotech Services Holdings Limited.
0.305 HKD
HKSE
SHL.AX
Sonic Healthcare Limited.
26.655 AUD
ASX
DGX
Quest Diagnostics Incorporated.
138.16 USD
NYSE
QIA.DE
Qiagen N.V..
40.345 EUR
XETRA
300685.SZ
Amoy Diagnostics Co., Ltd..
20.57 CNY
SHZ
603259.SS
WuXi AppTec Co., Ltd..
44.6 CNY
SHH
GTG.AX
Genetic Technologies Limited.
0.13 AUD
ASX

Korduma kippuv küsimus

Mis on IDEXX Laboratories, Inc. (IDXX) koguvara?

IDEXX Laboratories, Inc. (IDXX) koguvara on 3259925000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.601.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 9.589.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.233.

Mis on ettevõtte kogutulu?

Kogutulu on 0.300.

Mis on IDEXX Laboratories, Inc. (IDXX) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 845042000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 947880000.000.

Mis on tegevuskulude arv?

Tegevuskulud on 1092842000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.